EP0877610A4 - Inhibiteurs de farnesyl-proteine transferase - Google Patents

Inhibiteurs de farnesyl-proteine transferase

Info

Publication number
EP0877610A4
EP0877610A4 EP97907546A EP97907546A EP0877610A4 EP 0877610 A4 EP0877610 A4 EP 0877610A4 EP 97907546 A EP97907546 A EP 97907546A EP 97907546 A EP97907546 A EP 97907546A EP 0877610 A4 EP0877610 A4 EP 0877610A4
Authority
EP
European Patent Office
Prior art keywords
inhibitors
protein transferase
farnesyl protein
farnesyl
transferase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97907546A
Other languages
German (de)
English (en)
Other versions
EP0877610A1 (fr
Inventor
Christopher J Dinsmore
George D Hartman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9607124.6A external-priority patent/GB9607124D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP0877610A1 publication Critical patent/EP0877610A1/fr
Publication of EP0877610A4 publication Critical patent/EP0877610A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP97907546A 1996-01-30 1997-01-27 Inhibiteurs de farnesyl-proteine transferase Withdrawn EP0877610A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1108196P 1996-01-30 1996-01-30
US11081P 1996-01-30
GBGB9607124.6A GB9607124D0 (en) 1996-04-04 1996-04-04 Inhibitors of farnesyl-protein transferase
GB9607124 1996-04-04
PCT/US1997/001455 WO1997027853A1 (fr) 1996-01-30 1997-01-27 Inhibiteurs de farnesyl-proteine transferase

Publications (2)

Publication Number Publication Date
EP0877610A1 EP0877610A1 (fr) 1998-11-18
EP0877610A4 true EP0877610A4 (fr) 1999-09-15

Family

ID=26309063

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97907546A Withdrawn EP0877610A4 (fr) 1996-01-30 1997-01-27 Inhibiteurs de farnesyl-proteine transferase

Country Status (4)

Country Link
EP (1) EP0877610A4 (fr)
JP (1) JP2000505797A (fr)
AU (1) AU703988B2 (fr)
WO (1) WO1997027853A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2243507A1 (fr) * 1996-01-30 1997-08-07 Christopher J. Dinsmore Inhibiteurs de la farnesyl-proteine transferase
WO2000001382A1 (fr) 1998-07-02 2000-01-13 Merck & Co., Inc. Inhibiteurs de prenyl-proteine transferase
WO2000001701A1 (fr) 1998-07-02 2000-01-13 Merck & Co., Inc. Inhibiteurs de prenyl-proteine transferase
US7049324B1 (en) 1999-11-15 2006-05-23 Ashis Kumar Saha Triazoles as farnesyl transferase inhibitors
AU779426B2 (en) 1999-11-15 2005-01-27 Janssen Pharmaceutica N.V. Triazoles as farnesyl transferase inhibitors
US6380228B1 (en) 2000-04-10 2002-04-30 Merck & Co., Inc. Inhibitors of prenyl-protein transferase

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0236940A2 (fr) * 1986-03-07 1987-09-16 Ciba-Geigy Ag Tolunitriles substitués en position 1 par des hétérocycles

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571792A (en) * 1994-06-30 1996-11-05 Warner-Lambert Company Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase
US5534537A (en) * 1995-03-29 1996-07-09 Merck & Co., Inc. Prodrugs of inhibitors of farnesyl-protein transferase
US5578629A (en) * 1995-03-29 1996-11-26 Merck & Co., Inc. Benzamide-containing inhibitors of farnesyl-protein transferase

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0236940A2 (fr) * 1986-03-07 1987-09-16 Ciba-Geigy Ag Tolunitriles substitués en position 1 par des hétérocycles

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9727853A1 *

Also Published As

Publication number Publication date
AU703988B2 (en) 1999-04-01
JP2000505797A (ja) 2000-05-16
AU1952697A (en) 1997-08-22
WO1997027853A1 (fr) 1997-08-07
EP0877610A1 (fr) 1998-11-18

Similar Documents

Publication Publication Date Title
NO985405L (no) Inhibitorer av proteinfarnesyltransferase
NO983892L (no) Inhibitorer for farnesyl-proteintransferase
NO951266D0 (no) Imidazol-holdige inhibitorer for farnesyl-protein-transferase
EP0783318A4 (fr) Inhibiteurs de farnesyle-proteine transferase
FI941519L (fi) Farnesyyliproteiinitransferaasin heterosyklisiä inhibiittoreita
EE9700314A (et) Farnesüül-proteiini transferaasi inhibiitorid
EP0944388A4 (fr) Inhibiteurs de la farnesyl-proteine transferase
EP1011669A4 (fr) Inhibiteurs de la farnesyl-proteine transferase
EP0880320A4 (fr) Inhibiteurs de la farnesyl-proteine transferase
FI952010L (fi) Farnesyyliproteiinitransferaasin estäjät
EP0918771A4 (fr) Thiadioxobenzodiazepines utilises comme inhibiteurs de la farnesyle proteine transferase
FI952011L (fi) Farnesyyliproteiinitransferaasin estäjät
NO996571L (no) Inhibitorer for farnesyl-protein-transferase
EE9800146A (et) Farnesüülproteiintransferaasi inhibeerivad (5-imidasolüül)metüül-2-kinolinooni derivaadid
EP0891360A4 (fr) Inhibiteurs de la farnesyl-proteine transferase
ATE293622T1 (de) Farnesyl protein transferase inhibitoren
ATE214367T1 (de) Farnesyl transferase inhibitoren
EP0891352A4 (fr) Inhibiteurs de la farnesyl-proteine transferase
EP1035850A4 (fr) Inhibiteurs de la transferase de la farnesyl-proteine
EP1035852A4 (fr) Inhibiteurs de la farnesyl-proteine transferase
NO20012961D0 (no) Trisykliske farnesylproteintransferase-inhibitorer
EP1035849A4 (fr) Inhibiteurs de la transferase de la farnesyl-proteine
EP0842291A4 (fr) Inhibiteurs de farnesyl proteine-transferase
AU1952697A (en) Inhibitors of farnesyl-protein transferase
ZA971621B (en) Inhibitors of farnesyl protein transferase

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980831

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19990728

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

17Q First examination report despatched

Effective date: 20011011

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020222